Indications et conduite du traitement de l???infection tuberculeuse latente (ITL), Revue des Maladies Respiratoires, vol.25, issue.6, 2008. ,
DOI : 10.1016/S0761-8425(08)56018-9
L'organisation de la lutte antituberculeuse et la mise en oeuvre du programme de lutte contre la tuberculose en France, INVS, pp.12-13 ,
New tests for the Diagnosis of the Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for Research, Ann Intern Med, vol.146, pp.340-354, 2007. ,
Comparison of Tuberculin skin Testing and T-SPOT.TB for Diagnosis of Latent and Active Tuberculosis, Jpn. J. Infect. Dis, vol.63, pp.99-102, 2010. ,
New tests for the Diagnosis of the Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for Research, Ann Intern Med, vol.146, pp.340-354, 2007. ,
Latent Tuberculosis Diagnosis in Children by Using the QuantiFERON-TB Gold In-Tube Test, PEDIATRICS, vol.123, issue.1, pp.30-37, 2009. ,
DOI : 10.1542/peds.2007-3618
Adverse events associated with treatment of latent tuberculosis in the general population, CMAJ, vol.183, issue.3, 2011. ,
Rifampicin-isoniazid induced fatal fulminant hepatitis during treatment of latent tuberculosis: A case report and literature review, Indian Journal of Critical Care Medicine, vol.14, issue.2, pp.97-100, 2010. ,
DOI : 10.4103/0972-5229.68226
Severe Isoniazid-Associated Liver Injuries Among Persons Being Treated for latent Tuberculosis Infection-United States, 2004. ,
Traitement de la tuberculose sans prévue bactériologique: évaluation de la réponse au traitement et recherche des facteurs prédictifs de réponse ,
Paul Weinfurter and the Tuberculosis Epidemiologic Studies Consortium. Latent TB infection treatment acceptance and completion in the United States and Canada, Chest, vol.137, pp.401-409, 2010. ,
Adherance to treatment of latent tuberculosis infection in a clinical population in New York City, International Journal of infection diseases, vol.14, pp.292-297, 2010. ,
Short-Course Therapy with Rifampin plus Isoniazid, Compared with Standard Therapy with Isoniazid, for Latent Tuberculosis Infection: A Meta-analysis, Clinical Infectious Diseases, vol.40, issue.5, pp.670-676, 2005. ,
DOI : 10.1086/427802
Multi-Level Barriers to Latent Tuberculosis Infection Treatment: A research Note, J Immigrant Minority Health, vol.12, pp.544-550, 2010. ,
Trade-off between BCG vaccination and the ability to detect and treat latent tuberculosis, Journal of Theoretical Biology, vol.261, pp.548-560, 2009. ,
Couverture vaccinale par le BCG et épidémiologie de la tuberculose chez l'enfant : où en est-on un an après la levée de l'obligation vaccinale en France, INVS, pp.12-13 ,